Invention Grant
- Patent Title: Oxazolidin-2-one compounds and uses thereof
- Patent Title (中): 恶唑烷-2-酮化合物及其用途
-
Application No.: US14478523Application Date: 2014-09-05
-
Publication No.: US09458177B2Publication Date: 2016-10-04
- Inventor: Giorgio Caravatti , Robin Alec Fairhurst , Pascal Furet , Clive McCarthy , Heinrich Rueeger , Frank Hans Seiler , Frédéric Stauffer
- Applicant: Giorgio Caravatti , Robin Alec Fairhurst , Pascal Furet , Clive McCarthy , Heinrich Rueeger , Frank Hans Seiler , Frédéric Stauffer
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D498/04 ; C07D413/14 ; A61K31/5377 ; A61K45/06
Abstract:
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
Public/Granted literature
- US20140378450A1 OXAZOLIDIN-2-ONE COMPOUNDS AND USES THEREOF Public/Granted day:2014-12-25
Information query
